Codes / ICD10CM / M08.97

M08.97 Juvenile arthritis, unspecified, ankle and foot

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Juvenile Arthritis, Unspecified, Ankle and Foot

Summary

Juvenile arthritis, unspecified, ankle and foot refers to chronic inflammatory joint conditions in children and adolescents where the specific subtype is not documented, and the ankle and foot are the primary sites of involvement. It is characterized by joint inflammation, pain, and stiffness localized to these areas, and may involve systemic symptoms in some cases. The term "unspecified" indicates a lack of detailed clinical information about the exact type or extent of the condition.

Causes

The exact cause is unknown, but juvenile arthritis is believed to be an autoimmune disorder where the immune system mistakenly attacks healthy joint tissues. Genetic factors and environmental triggers may contribute to its development, though specific triggers are not always identifiable.

Risk Factors

  • Family history of autoimmune diseases.
  • Age (most commonly diagnosed in children under 16).
  • Female gender (higher prevalence in certain subtypes).
  • Possible links to infections or other environmental factors.

Symptoms

  • Joint pain, swelling, and stiffness in the ankle or foot, often worse in the morning.
  • Reduced range of motion in the affected ankle or foot.
  • Systemic symptoms (e.g., fever, rash) in some cases.
  • Fatigue and general malaise.

Diagnosis

Diagnosis involves a combination of clinical evaluation, medical history, and diagnostic tests. Physical examination assesses joint involvement, while blood tests (e.g., inflammatory markers, autoantibodies) and imaging (e.g., X-rays or MRI) may help rule out other conditions and evaluate joint damage.

Treatment Options

Treatment focuses on reducing inflammation, managing pain, and preserving joint function. Options may include nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), physical therapy, and in some cases, corticosteroid injections. Treatment plans are tailored to the individual’s symptoms and response.

Prognosis and Follow-Up

Prognosis varies depending on the severity and response to treatment. Early intervention can improve outcomes, but some individuals may experience long-term joint damage or persistent symptoms. Regular follow-up with a healthcare provider is essential to monitor disease activity and adjust treatment as needed.

Complications

Potential complications include joint deformity, growth abnormalities, vision problems (e.g., uveitis), and reduced mobility. Systemic involvement may lead to additional organ-related issues in rare cases.

Lifestyle & Prevention

While juvenile arthritis cannot be prevented, maintaining a healthy lifestyle may support overall well-being. This includes regular exercise (as tolerated), a balanced diet, and adequate rest. Protecting joints from excessive strain and following prescribed treatment plans can help manage symptoms.

When to Seek Professional Help

Seek medical attention if symptoms worsen, new joint swelling or pain develops, or systemic symptoms (e.g., fever, rash) occur. Prompt evaluation is important to adjust treatment and prevent complications.

Tips for Medical Coders

When coding M08.97, ensure the documentation specifies juvenile arthritis with ankle and foot involvement as the primary site. The "unspecified" designation indicates the subtype is not documented, so no further specificity about the arthritis type (e.g., rheumatoid, psoriatic) should be assumed. Verify that the diagnosis aligns with clinical findings and that the site (ankle and foot) is clearly supported by the record.

Book a walkthrough

M08.97 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.